Health
Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study – News-Medical.Net
A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating SARS-CoV-2 variants with multiple…
A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with multiple spike mutations.
The study’s findings reveal that the variants containing Y543F or N501Y spike mutations are capable of evading neutralization by SARS-CoV-2-induced antibodies. However, no such immune evading potency has been observed for the variants with only the E484K spike mutation.
…
-
Noosa News16 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News17 hours agoMotorcyclist dies in crash with truck
-
Noosa News17 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General22 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging